Real-world experience of cariprazine use for negative symptoms in schizophrenia-spectrum disorders - a case series

被引：0
|
作者：
Fernandes, L. A. [1 ]
Magalhaes, D. [1 ]
Viegas, F. [1 ]
Pedro, J. [1 ]
Gasparinho, R. [2 ]
Santos, M. J. [1 ]
机构：
[1] Hosp Prof Doutor Fernando Fonseca EPE, Psychiat, Lisbon, Portugal
[2] Hosp Distrital Santarem, Psychiat, Santarem, Portugal
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2021年 / 53卷
关键词：
D O I：
10.1016/j.euroneuro.2021.10.858
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.0795
引用
收藏
页码：S581 / S581
页数：1
相关论文
共 50 条
  • [41] Alcohol and cannabis use in urban, African American, first-episode schizophrenia-spectrum patients: Associations with positive and negative symptoms
    Compton, Michael T.
    Whicker, Neil E.
    Hochman, Karen M.
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2007, 68 (12) : 1939 - 1945
  • [42] Isavuconazole - The Real-World Use Experience.
    Hassouna, H.
    Athans, V.
    Brizendine, K.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2018, 18 : 889 - 889
  • [43] Real-world effectiveness of mood stabilizer use in schizophrenia
    Puranen, Arto
    Koponen, Marjaana
    Lahteenvuo, Markku
    Tanskanen, Antti
    Tiihonen, Jari
    Taipale, Heidi
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2023, 147 (03) : 257 - 266
  • [44] From evidence to clinical experience: three cases of community patients with negative symptoms of schizophrenia and treated with cariprazine
    Rana, Tanvir
    Andre, Valentina
    [J]. MINERVA PSYCHIATRY, 2023, 64 (02): : 270 - 271
  • [45] Emotional interference and attentional control in schizophrenia-spectrum disorders: The special case of neutral faces
    Grave, Joana
    Madeira, Nuno
    Morais, Sofia
    Rodrigues, Paulo
    Soares, Sandra C.
    [J]. JOURNAL OF BEHAVIOR THERAPY AND EXPERIMENTAL PSYCHIATRY, 2023, 81
  • [46] Behavioural activation as a potential treatment of negative symptoms in schizophrenia spectrum disorders
    Cernvall, M.
    [J]. EARLY INTERVENTION IN PSYCHIATRY, 2008, 2 : A102 - A102
  • [47] A Retrospective Case Series of Telavancin for the Treatment of Staphylococcus aureus Bacteremia: A Real-World Experience
    Saravolatz, Louis D.
    Cleveland, Kerry O.
    Rikabi, Khalid
    Hassoun, Ali
    Reilly, Joseph
    Johnson, Leonard B.
    Spak, Cedric
    Valenti, Sharon
    Szpunar, Susan
    [J]. INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2018, 26 (05) : 264 - 269
  • [48] An update on clinical insight, cognitive insight, and introspective accuracy in schizophrenia-spectrum disorders: symptoms, cognition, and treatment
    Mervis, Joshua E.
    Vohs, Jenifer L.
    Lysaker, Paul H.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2022, 22 (03) : 245 - 255
  • [49] Relationship between neurocognitive function and clinical symptoms with self-stigma in patients with schizophrenia-spectrum disorders
    Chan, Sherry Kit Wa
    Kao, Shiao Yan Sharon
    Leung, Shing Lam
    Hui, Christy Lai Ming
    Lee, Edwin Ho Ming
    Chang, Wing Chung
    Chen, Eric Yu Hai
    [J]. JOURNAL OF MENTAL HEALTH, 2019, 28 (06) : 583 - 588
  • [50] Efficacy of esketamine in the treatment of negative symptoms in schizophrenia - A case series
    Nunes, Marcel V.
    Adelino, Marcelo P. M.
    Ajub, Elias
    Quarantini, Lucas C.
    Lacerda, Acioly L. T.
    [J]. SCHIZOPHRENIA RESEARCH, 2018, 202 : 394 - 396
12345